ENTITY

Luye Pharma (2186 HK)

90

Analysis

Health Care • China

Luye Pharma Group Ltd focuses on the research and development, production, and sales of pharmaceutical drugs for orthopedics, neurology, gastroenterology, and hepatology. The Company also sells active ingredients, R&D results, and patents of new drugs, as well as providing research services on a contractual basis.

more

Refresh

Exchange Announcement • 23 Jul 2024 08:00

Discloseable Transaction Third Party Investment In Shenzhen Luye

Exchange Announcement • 04 Jul 2024 19:00

Voluntary Announcement - Mimeixin (Oxycodone Hydrochloride And Naloxone Hydrochloride Sustained-Release Tablets) Approved For Marketing In China

Exchange Announcement • 27 Jun 2024 21:45

Voluntary Announcement - The Manufacturing Facility Of Paliperidone Palmitate Extended-Release Injectable Suspension (Ly03010) Has Passed Pai By U.S. Fda With No Fda-483

Exchange Announcement • 20 Jun 2024 19:00

Voluntary Announcement - Jinyouping (Rotigotine Microspheres For Injection) Approved For Marketing In China

Exchange Announcement • 11 Jun 2024 20:00

Voluntary Announcement - Meibirui (Paliperidone Palmitate Injection) Approved For Marketing In China

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9

x